Research Topics
| Julia StoweSummaryAffiliation: Health Protection Agency Country: UK Publications
|
Detail Information
Publications
No evidence of an increase of bacterial and viral infections following Measles, Mumps and Rubella vaccineJulia Stowe
Immunisation Department, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
Vaccine 27:1422-5. 2009....- Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research DatabaseJulia Stowe
Immunisation Department, Health Protection Agency Centre for Infections, London, UK
Am J Epidemiol 169:382-8. 2009.... - Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case seriesNick Andrews
Statistics Modelling and Economics Department, Health Protection Services, Health Protection Agency, Colindale, London NW9 5EQ, United Kingdom
Vaccine 29:7878-82. 2011..05 [95% confidence interval (CI) 0.37 to 2.24]). We found no evidence of an increased risk of GBS in the 6 weeks following pandemic influenza vaccination... - Bell's palsy and parenteral inactivated influenza vaccineJulia Stowe
Immunisation Department, Health Protection Agency Centre for Infections, London, UK
Hum Vaccin 2:110-2. 2006..78-1.08). There was also no evidence of an increased risk in any age group or following pneumococcal vaccine. A significant increase was seen on the day of vaccination (day 0) probably due to opportunistic recording of cases... - No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndromeBrent Taylor
General and Adolescent Paediatric Unit, Institute of Child Health, University College London, London, UK
Arch Dis Child 92:887-9. 2007..To investigate whether meningococcal C conjugate vaccine (MCCV) caused relapse in children with steroid-responsive nephrotic syndrome... - The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and WalesMark Jit
Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 6BT, United Kingdom
Vaccine 29:115-22. 2010..Key sources of uncertainty are the cost of vaccine delivery and the quality of life detriment due to a clinically apparent episode of confirmed influenza. The cost of vaccine purchase itself is relatively low... - Post-licensure safety of the meningococcal group C conjugate vaccineNick Andrews
Statistics Unit, Health Protection Agency, Centre for Infections, London, UK
Hum Vaccin 3:59-63. 2007..15 (0.80-1.67). There was evidence of an increased risk of convulsions and idiopathic thrombocytopenic purpura following MMR vaccination as previously documented... - Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United KingdomNick Andrews
Statistics Unit, Health Protection Agency, Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
Vaccine 28:7215-20. 2010..Although there were no other significant differences between vaccines the relative incidence was significantly above one on the day of vaccination for convulsions following DTwP/Hib and for apnoea/collapse following DTaP(5)/Hib/IPV... - Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal associationNick Andrews
Statistics Unit, Health Protection Agency, Communicable Disease Surveillance Centre, London, United Kingdom
Pediatrics 114:584-91. 2004..CONCLUSIONS: With the possible exception of tics, there was no evidence that thimerosal exposure via DTP/DT vaccines causes neurodevelopmental disorders... - Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: A database studyJulia Stowe
Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, London, United Kingdom
Vaccine 29:9467-72. 2011..These results neither provide evidence of an increased risk of convulsions following TIV over a 10-year surveillance period nor following a single dose of the ASO3 adjuvanted monovalent H1N1 vaccine in 2009/10...